Are you or someone you know battling treatment-resistant Lyme Disease?
Discover new avenues of hope through our groundbreaking clinical trial at The Biologix Center for Optimum Health.
About the Study:
With IRB support, we’re committed to replicating our early positive outcomes consistently. Our approach targets the underlying microbial infections, including Borrelia and other co-infections commonly associated with Lyme Disease. Learn more about the virome and its role in maintaining human health.
Treatment Details:
Participate in comprehensive treatments and supportive therapies daily (Monday to Friday). Understand what to expect during our program of care.
Embark on a one-to-two-week program of care, supplemented by virtual follow-up appointments.
Experience a personalized approach with induced native phage therapy, offering a safe and non-allergenic treatment option.
Goal:
Our primary goal is to reduce or eliminate the causative bacterial and microbial infections, along with their toxins, to alleviate symptoms and improve overall well-being.
Prerequisites:
Recent Phelix Borrelia-Phage laboratory test results demonstrating positivity for one or more types of Borrelia and a commitment to retesting with the Phelix Borrelia-Phage Test post-treatment.